Sulima, А.Е. It is an antiviral medication that helps to reduce the pain and severity of herpes lesions or sores. Daklinza (Daclatasvir Dihydrochloride) is prescription medication used to treat chronic hepatitis C in patients older than 18 years. 4 Kuznetsova А.V. Home; Drugs and Medications A-Z; Z; Zovirax Cream; Zovirax Cream (acyclovir topical) DIN (Drug Identification Number) 02039524 ZOVIRAX 5% CREAM. Dubotolkina, L.I. How does this … Kostakova // Clinical pharnacology and therapy. At Phs-Leksredstva JSC 8 manufacturing areas are compliant with European Union Good Manufacturing Practices and EU GMP-certified.Pharmstandard is one of the leading market players in the field of localization of innovative pharmaceutical product manufacturing in Russia within the frames of partnership agreements with international pharmaceutical companies.The company’s products are supplied throughout the Russian Federation and abroad.1 Instruction for medicinal use of medicinal product Daklinza®. PHARMACY MANAGER: SANAA ABDELATICopyright © 2003 - 2020 Canadian Pharmacy King. If you require any advice or information about the drugs on this page, a medical condition or treatment advice, you should always speak to a health professional. Common side effects with sofusbivir and daclatasvir … Order Daklinza (Daclatasvir Dihydrochloride) from Canada, at lower prices to the U.S. Daklinza contains an active substance called Daclatasvir that works by stopping the virus from multiplying and infecting liver cells. Kuznetsova, Е.B. Daklinza® is an inhibitor of Hepatitis C virus (HCV) non-structural protein 5А (NS5A), direct-acting antiviral to treat Hepatitis С within complex therapy for adult patients (Marketing Authorization RU LP-003088 of 07.14.2015)¹. It is also used for the acute treatment of herpes zoster (shingles) and varicella (chickenpox). The content on this page has been supplied to canadianpharmacyking by an independent third party contracted to provide information for our website. The price reduction records have been entered in the State Register of Maximum Manufacturer`s Selling Prices for Medicines.Daklinza® is an inhibitor of Hepatitis C virus (HCV) non-structural protein 5А (NS5A), direct-acting antiviral to treat Hepatitis С within complex therapy for adult patients (Marketing Authorization RU LP-003088 of 07.14.2015)¹.Within our country the number of infected with Hepatitis C virus may reach 4.2 million patients that is 2.9 percent of the adult population.² For the period from January to November 2019³ 41.5 thousand patients were officially first diagnosed with Chronic Hepatitis C (CHC). Please note that not all products, including any referenced in this page, are shipped by our affiliated Canadian Pharmacy. – V. 23, № 4. It is an additional opportunity to move forward in fighting against socially significant infectious diseases and to ensure an access to innovative iterferon-free therapy for as many patients living with Hepatitis C virus in our country” – highlighted the importance of decision Grigory Potapov, CEO of Pharmstandard JSC.It is worth reminding that in July 2019 Pharmstandard and Bristol-Myers Squibb (BMS) executed the agreement to assign to the Russian company the rights to manufacture, sell and distribute medicinal product Daklinza® within the territory of Russia and EAEU countries. Tell your doctor about all the medical conditions you have had before.
The increasing of CHC patient coverage provided with the effective treatment by direct-acting antiviral is a measure to improve the epidemiological situation.⁴In our country before the reduction, the maximum selling price for Daklinza® 60 mg was 67,946.67 Rubles per pack (excluding VAT and regional additional charges). Tchernog, V.V.